Expertise in
93
conditions

Tao J. Jiang

China Japan Union Hospital Of Jilin University
Changchun, CN 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
93
conditions
China Japan Union Hospital Of Jilin University
Changchun, CN 
OverviewLocationsClinical Research

Overview

Tao Jiang practices in Changchun, China. Jiang is highly rated in 93 conditions, according to our data. Their top areas of expertise are Glioma, Gliomatosis Cerebri, Brain Tumor, Sleeve Gastrectomy, and Gastrectomy.

Their clinical research consists of co-authoring 3720 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

China Japan Union Hospital of Jilin University
Changchun, 130033, China
Other Locations
87 Xiangya Road, Changsha, 410008, China
Yuehua Street, Kunming, 650504, China
Union Hospital, Wuhan, 430022, China
No. 119 South 4th Ring West Road, Fengtai, 100070, China
804 Shengli Road, Yinchuan, 750004, China
300 Guangzhou Rd, Nanjing, 210029, China
Fujian Medical University Union Hospital, No. 29 Xinquan Street, Fuzhou, 350001, China
No.1 Daxue Road, Xuzhou, 221116, China
No. 1, Xinsi Road, Xi'an, China
No. 16, Jiangsu Road, Qingdao, 266003, China
No. 1095 Jiefang Avenue, Wuhan, 430030, China
157 Jinbi Road, Kunming, 650032, China
No. 866 Yuhangtang Road, Hangzhou, 310058, China
246 Xuefu Road, Harbin, 150086, China
No. 507, Zheng Min Road, Shanghai, 200433, China
No. 169 Changle West Road, Xi'an, 710032, China
No. 393 Xinyi Road, Ueruemqi, 830000, China
84 West Huaihai Road, Xuzhou, 221002, China
100 Haining Road, Shanghai, 200080, China
1200 Cailun Road, Pudong, China
79 Qingchun Road, Hangzhou, 310003, China
No.5 Jingyuan Road, Shijingshan, 100043, China
1 Xinsi Road, Xi'an, 710038, China
122 Luoshi Road, Wuhan, 430070, China
38 Zheda Road, Hangzhou, 310027, China
1200 Cailun Road, Shanghai, 201203, China
No. 77 Puhe Road, Shenyang, 110122, China
No.569 Xinsi Road, Xi'an, 710038, China
123 Tianfei Road, Nanjing, 210004, China
No. 160 Pudian Road, Shanghai, China
804 South Shengli Road, Yinchuan, 750004, China
Guangzhou Branch, Guangzhou, China
36 Sanhao Street, Shenyang, 110004, China
25 Heping North Road, Changzhou, 213003, China
Nangang District, PR, Harbin, China
State Cultivation Base Of Eco Agriculture For Southwest Mountainous Land, Chongqing, 400716, China
Zheng Min Road, Shanghai, 200433, China
NO.8 GongTi South Road, Beijing, 100020, China
Key Laboratory Of Fishery Ecological Environment Assessment And Resource Conservation In Middle And Lower Reaches Of The Yangtze River, Wuxi, China
No. 10, Tieyi Road, Haidian, 100038, China
318 Chaowang Road, Hangzhou, 310005, China
No. 137, Li Yu Shan Street, Ueruemqi, 830011, China
155# Chang Bai Road, Changping, 102206, China
85 Wujin Road, Shanghai, 200080, China
138 Yixueyuan Road, Xuhui, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Multicenter Randomized, Controlled Phase III Clinical Trial of Pembrolizumab Plus Paclitaxel and Cisplatin Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Locally Advanced Esophageal Squamous Cell Carcinoma (KEYSTONE-002)
A Multicenter Randomized, Controlled Phase III Clinical Trial of Pembrolizumab Plus Paclitaxel and Cisplatin Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Locally Advanced Esophageal Squamous Cell Carcinoma (KEYSTONE-002)
Enrollment Status: Recruiting
Publish Date: June 01, 2022
Intervention Type: Biological, Radiation, Drug
Study Drugs: Pembrolizumab, Paclitaxel, Cisplatin
Study Phase: Phase 3
LIBRETTO-432: A Placebo-controlled Double-Blinded Randomized Phase 3 Study of Adjuvant Selpercatinib Following Definitive Locoregional Treatment in Participants With Stage IB-IIIA RET Fusion-Positive NSCLC
LIBRETTO-432: A Placebo-controlled Double-Blinded Randomized Phase 3 Study of Adjuvant Selpercatinib Following Definitive Locoregional Treatment in Participants With Stage IB-IIIA RET Fusion-Positive NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: October 21, 2025
Intervention Type: Drug
Study Drug: Selpercatinib
Study Phase: Phase 3
Predicting Neoadjuvant Therapy Response of Rectal Cancer With MRI
Predicting Neoadjuvant Therapy Response of Rectal Cancer With MRI
Enrollment Status: Unknown
Publish Date: June 22, 2023
Intervention Type: Device
Study Phase: Not Applicable
View 2 Less Clinical Trial

3718 Total Publications

(±)-Rutacycoumarins A and B: two pairs of unprecedented coumarin enantiomers from the aerial part of Ruta graveolens L. and chemically synthesized.
(±)-Rutacycoumarins A and B: two pairs of unprecedented coumarin enantiomers from the aerial part of Ruta graveolens L. and chemically synthesized.
Journal: Pharmaceutical biology
Published: December 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Jiang's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 9 Distinguished Conditions
View All 77 Advanced Conditions
View All 333 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile